Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 35, 2000 - Issue 3
Submit an article Journal homepage
41
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of Different Helicobacter pylori Eradication Regimens in Patients Affected by Insulin-Dependent Diabetes Mellitus

A. Gasbarrini, V. Ojetti, D. Pitocco, A. Armuzzi, N. Gentiloni Silveri, P. Pola, G. Ghirlanda, G. Gasbarrini Istituto di Patologia Medica, Università Cattolica del S. Cuore, Policlinico Gemelli, Largo Gemelli 8, I-00168 Rome, Italy
Pages 260-263 | Published online: 08 Jul 2009

Citations (38)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chih-Chien Yao, Chung-Mou Kuo, Chien-Ning Hsu, Shih-Cheng Yang, Cheng-Kun Wu, Wei-Chen Tai, Chih-Ming Liang, Keng-Liang Wu, Chih-Fang Huang, Kuo-Wei Bi, Chen-Hsiang Lee & Seng-Kee Chuah. (2019) First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus. Infection and Drug Resistance 12, pages 1425-1431.
Read now

Articles from other publishers (37)

Om Saswat Sahoo, Rhiti Mitra, Arghyadeep Bhattacharjee, Samarjit Kar & Oindrilla Mukherjee. (2023) Is Diabetes Mellitus a Predisposing Factor for Helicobacter pylori Infections?. Current Diabetes Reports 23:8, pages 195-205.
Crossref
Igor V. Maev, Ashot M. Mkrtumyan, Luiza G. Bektemirova, Dmitry N. Andreev & Diana T. Dicheva. (2022) The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus. Terapevticheskii arkhiv 94:2, pages 209-215.
Crossref
Xin Song, Changzhou Cai, Qi Jin, Xueyang Chen & Chaohui Yu. (2021) The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis . Helicobacter 26:2.
Crossref
Kamyar Mansori, Hojat Dehghanbanadaki, Sara Naderpour, Roya Rashti, Ali Baradaran Moghaddam & Yousef Moradi. (2020) A systematic review and meta-analysis of the prevalence of Helicobacter pylori in patients with diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14:4, pages 601-607.
Crossref
L. G. Bektemirova, D. N. Andreev, A. M. Mkrtumyan & D. T. Dicheva. (2019) Diabetes mellitus as a cause of inefficiency of eradication therapy of Helicobacter pylori infection: a systematized literature review. Medical Council:14, pages 32-38.
Crossref
Juan C. Gómez-Izquierdo & Oriana Hoi Yun Yu. (2017) The Influence of Proton-Pump Inhibitors on Glycemic Control: A Systematic Review of the Literature and a Meta-Analysis. Canadian Journal of Diabetes 41:4, pages 351-361.
Crossref
Jiyeon YooYeong Ji YuGumin ChoHongkwon OhSeung Hyun OhTae Ho KimJung Hwan Oh. (2017) Helicobacter pylori Eradication Rate in Patients with Diabetes . The Korean Journal of Helicobacter and Upper Gastrointestinal Research 17:2, pages 83.
Crossref
Ferdane Sapmaz, Ismail H Kalkan, Incilay Suslu, Hüseyin Demirci, Pinar Atasoy & Sefa Guliter. (2015) Lower plasma pantoprazole level predicts Helicobacter pylori treatment failure in patients with type 2 diabetes mellitus . Journal of Digestive Diseases 16:9, pages 531-536.
Crossref
Yi-Ning Dai. (2015) Is Helicobacter pylori infection associated with glycemic control in diabetics? . World Journal of Gastroenterology 21:17, pages 5407.
Crossref
J. P. Gisbert, A. Perez-Aisa, L. Rodrigo, J. Molina-Infante, I. Modolell, F. Bermejo, M. Castro-Fernández, R. Antón, B. Sacristán, A. Cosme, J. Barrio, Y. Harb, M. Gonzalez-Barcenas, M. Fernandez-Bermejo, A. Algaba, A. C. Marín & A. G. McNicholl. (2013) Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection. Digestive Diseases and Sciences 59:2, pages 383-389.
Crossref
Hyung Hun Kim. (2013) Helicobacter pylori Infection and Metabolic Disease . Korean Journal of Medicine 84:6, pages 781.
Crossref
Javier P. Gisbert. (2012) Rescue Therapy for Helicobacter pylori Infection 2012 . Gastroenterology Research and Practice 2012, pages 1-12.
Crossref
Hilmi Ataseven, Mehmet Demir & Ramazan Gen. (2010) Effect of Sequential Treatment as a First-Line Therapy for Helicobacter pylori Eradication in Patients with Diabetes Mellitus. Southern Medical Journal 103:10, pages 988-992.
Crossref
Christian Selinger & Andrew Robinson. (2010) Helicobacter pylori Eradication in Diabetic Patients: Still Far Off the Treatment Targets. Southern Medical Journal 103:10, pages 975-976.
Crossref
Mehmet Demir, Huseyin Savas Gokturk, Nevin Akcaer Ozturk, Ender Serin & Ugur Yilmaz. (2009) Efficacy of Two Different Helicobacter pylori Eradication Regimens in Patients With Type 2 Diabetes and the Effect of Helicobacter pylori Eradication on Dyspeptic Symptoms in Patients With Diabetes: A Randomized Controlled Study. The American Journal of the Medical Sciences 338:6, pages 459-464.
Crossref
Javier P. Gisbert. (2009) Review: Second-line rescue therapy of Helicobacter pylori infection . Therapeutic Advances in Gastroenterology 2:6, pages 331-356.
Crossref
Mehmet Demir, Huseyin Savas Gokturk, Nevin Akcaer Ozturk, Hande Arslan, Ender Serin & Ugur Yilmaz. (2009) Clarithromycin Resistance and Efficacy of Clarithromycin-Containing Triple Eradication Therapy for Helicobacter pylori Infection in Type 2 Diabetes Mellitus Patients. Southern Medical Journal 102:11, pages 1116-1120.
Crossref
Ji Hyun KimJeong Seop MoonSam Ryong JeeWoon Geon ShinSoo-Heon Park. (2009) Guidelines of Treatment for Peptic Ulcer Disease in Special Conditions. The Korean Journal of Gastroenterology 54:5, pages 318.
Crossref
Konstantinos X Papamichael, Garyphallia Papaioannou, Helen Karga, Anastasios Roussos & Gerassimos J Mantzaris. (2009) Helicobacter pylori infection and endocrine disorders: Is there a link?. World Journal of Gastroenterology 15:22, pages 2701.
Crossref
Mohamed Abdullahi, Bruno Annibale, Danila Capoccia, Roberto Tari, Edith Lahner, John Osborn, Frida Leonetti & Carola Severi. (2008) The Eradication of Helicobacter pylori is Affected by Body Mass Index (BMI). Obesity Surgery 18:11, pages 1450-1454.
Crossref
Alexander C Ford, Peter Malfertheiner, Monique Giguère, José Santana, Mostafizur Khan & Paul Moayyedi. (2008) Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis. World Journal of Gastroenterology 14:48, pages 7361.
Crossref
Javier P Gisbert. (2008) “Rescue” regimens after Helicobacter pylori treatment failure. World Journal of Gastroenterology 14:35, pages 5385.
Crossref
R. Promberger, M. Gadenstätter, R. Ciovica, G. Schwab & C. Neumayer. (2007) Gastroesophageal reflux disease in diabetic patients: a systematic reviewGastroösophageale Refluxkrankheit bei Diabetikern: eine systematische Übersicht. European Surgery 39:6, pages 340-354.
Crossref
J. P. GISBERT & F. MORENA. (2006) Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Alimentary Pharmacology and Therapeutics 23:1, pages 35-44.
Crossref
Javier P. Gisbert, Leticia Gonzalez & Xavier Calvet. (2005) Systematic Review and Meta-analysis: Proton Pump Inhibitor vs. Ranitidine Bismuth Citrate Plus Two Antibiotics in Helicobacter pylori Eradication. Helicobacter 10:3, pages 157-171.
Crossref
J. P. Gisbert, J. Fuentes, D. Carpio, L. Tito, J. Guardiola, A. Tomas, D. Olivares & X. Calvet. (2005) 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure. Alimentary Pharmacology and Therapeutics 21:10, pages 1249-1253.
Crossref
Javier P Gisbert, Sam Khorrami, Xavier Calvet & Jos?? Mar??a Pajares. (2004) Pantoprazole based therapies in Helicobacter pylori eradication. European Journal of Gastroenterology & Hepatology 16:1, pages 89-99.
Crossref
E. C. Nista, M. Candelli, F. Cremonini, I. A. Cazzato, S. Di Caro, M. Gabrielli, L. Santarelli, M. A. Zocco, V. Ojetti, E. Carloni, G. Cammarota, G. Gasbarrini & A. Gasbarrini. (2003) Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial . Alimentary Pharmacology & Therapeutics 18:6, pages 627-633.
Crossref
F Parente, C Cucino & G Bianchi Porro. (2003) Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. Digestive and Liver Disease 35:8, pages 523-528.
Crossref
Javier P. Gisbert & José María Pajares. (2003) Treatment of helicobacter pylori eradication failures. Current Treatment Options in Gastroenterology 6:2, pages 147-156.
Crossref
Mehmet Sargýn. (2003) Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori . World Journal of Gastroenterology 9:5, pages 1126.
Crossref
Veronica Ojetti, Dario Pitocco, Francesco Bartolozzi, Silvio Danese, Alessio Migneco, Andrea Lupascu, Paolo Pola, Giovanni Ghirlanda, Giovanni Gasbarrini & Antonio Gasbarrini. (2002) High Rate of Helicobacter pylori Re-Infection in Patients Affected by Type 1 Diabetes . Diabetes Care 25:8, pages 1485-1485.
Crossref
D. Boixeda, F. Bermejo, C. Martín‐De‐Argila, A. López‐Sanromán, V. Defarges, F. Hernández‐Ranz, J. M. Milicua & A. García‐Plaza. (2002) Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection . Alimentary Pharmacology & Therapeutics 16:8, pages 1457-1460.
Crossref
J. P. Gisbert & J. M. Pajares. (2002) Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor‐based triple therapies fail . Alimentary Pharmacology & Therapeutics 16:6, pages 1047-1057.
Crossref
M. J. R. Janssen, A. H. A. M. Van Oijen, A. L. M. Verbeek, J. B. M. J. Jansen & W. A. De Boer. (2002) A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole . Alimentary Pharmacology & Therapeutics 15:5, pages 613-624.
Crossref
Javier P. Gisbert & José María Pajares. (2001) <i>Helicobacter pylori</i> Therapy: First-Line Options and Rescue Regimen. Digestive Diseases 19:2, pages 134-143.
Crossref
James S. Hoffman & David R. Cave. (2001) Treatment of Helicobacter pylori. Current Opinion in Gastroenterology 17:1, pages 30-34.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.